SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Poland GA, Ovsyannikova IG, Kennedy RB. Lancet 2020 Oct 13. pii: S0140-6736(20)32137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Poland GA, Ovsyannikova IG, Kennedy RB. SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet 2020 Oct 13. pii: S0140-6736(20)32137.
PMID: 33065034